POSA197 Modeled Impact of Nirsevimab Against Respiratory Syncytial Virus (RSV) Among UK Infants Experiencing Their First RSV Season

Abstract

Authors

M Beuvelet C Davidson R Hudson A Kieffer

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×